Association between vitamin D receptor gene haplotypes and chronic periodontitis among Japanese men by Naito, Mariko et al.
Int. J. Med. Sci. 2007, 4 
 
216
International Journal of Medical Sciences 
ISSN 1449-1907 www.medsci.org 2007 4(4):216-222 
©Ivyspring International Publisher. All rights reserved 
Research Paper 
Association between vitamin D receptor gene haplotypes and chronic 
periodontitis among Japanese men 
Mariko Naito 1, Koichi Miyaki 2, Toru Naito 3, Ling Zhang 4, Keika Hoshi 5, Asako Hara 6, Katsunori Masaki 6, 
Shugo Tohyama 6, Masaaki Muramatsu4, Nobuyuki Hamajima 1, Takeo Nakayama 2 
1.  Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of 
Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan   
2.  Department of Health Informatics, Kyoto University School of Public Health, Yoshida konoe-cho, Sakyo-ku, Kyoto, 
606-8501, Japan 
3.  Department of General Dentistry, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku, Fukuoka, 814-0193, Japan   
4.  Department of Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, 2-3-10 
Kandasurugadai, Chiyoda-ku, Tokyo, 101-0062, Japan 
5.  Information Design Section, Center for Information Research and Library, National Institute of Public Health, 2-3-6 
Minami, Wako, Saitama, 351-0197, Japan 
6.  Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan   
Correspondence to: Mariko Naito, Tel: +81-52-744-2132, Fax: +81-52-744-2971, E-mail: mnaito@med.nagoya-u.ac.jp 
Received: 2007.06.30; Accepted: 2007.08.20; Published: 2007.08.22 
Background: The vitamin D receptor (VDR) is involved in a variety of biological processes, such as bone 
metabolism and modulation of the immune response. Recent findings suggest that the pathway involving bone 
mineral density-mediated effects is important for the development of periodontitis, but their effects of combined 
VDR gene polymorphisms have not been confirmed on periodontitis. We assessed the relationship between 
ApaI, BsmI, and FokI VDR polymorphisms and the risk of severe chronic periodontitis among Japanese adult 
men. 
Materials and Methods: In a cross-sectional study, we examined 97 unrelated healthy Japanese men (mean age: 
45.6 years, range: 22-59). A clinical examination was performed at a worksite health checkup, and information 
was obtained using a self-reported questionnaire. DNA was extracted from whole blood, and the VDR ApaI, 
BsmI, and FokI polymorphisms were genotyped using polymerase chain reaction. 
Results: F-carriers of FokI VDR polymorphisms were less likely to develop severe chronic periodontitis than 
non-F-carriers (p = 0.09). The ApaI and BsmI VDR polymorphisms did not show significant differences in the 
alleles or genotypes between the subjects with or without severe chronic periodontitis. The haplotype analysis of 
the three combined VDR polymorphisms revealed that the Abf homozygote had a notably higher prevalence of 
severe chronic periodontitis than the others, and adjustments for age, smoking status, number of teeth present, 
and prevalence of diabetes did not change this association (OR = 7.5; 95% CI = 1.6-34.4; p = 0.01). 
Conclusion: The VDR haplotype constructed from the ApaI, BsmI, and FokI polymorphisms is related to the risk 
of severe chronic periodontitis in Japanese men. 
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1.  INTRODUCTION  
Periodontal disease is a chronic infection that 
requires the presence of specific bacteria for disease 
initiation and progression. Moreover, genetic factors 
may play a role in determining the host’s response to 
infection and could account for significant variation in 
its clinical severity [1]. 
Vitamin D influences the development of 
periodontal disease through both immunomodulatory 
effects and an effect on bone mineral density (BMD) 
[2,3]. Dietrich et al. [4] reported a statistically 
significant inverse association between serum 
25(OH)D3 concentrations and periodontal disease in 
people aged 50 years or older. Vitamin D has an 
important role in bone formation and preservation [5], 
and several epidemiological studies have reported 
positive associations between osteoporosis or low 
bone density and alveolar bone and tooth loss, which 
suggests that poor bone quality is a risk factor for 
developing periodontal disease [6-8]. Recent findings 
suggest that alveolar bone loss in periodontal disease 
is more pronounced in osteoporotic bone [9] and that 
the pathway involving BMD-mediated effects is 
important for the development of periodontitis [4]. 
The vitamin D receptor (VDR) is involved in a 
variety of biological processes, such as bone 
metabolism and modulation of the immune response, 
in which it functions as a vitamin D3-dependent 
transcription factor [10]. Several polymorphisms have 
been identified in the VDR gene, most of which are Int. J. Med. Sci. 2007, 4 
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identified by biallelic variation in restriction enzyme 
sites. Examples of restriction fragment length 
polymorphisms (RFLPs) in the VDR gene include 
Tru9I [11], TaqI [12], BsmI [13], EcoRV [13], ApaI [14], 
and FokI [15,16]. All these RFLPs, except FokI in exon 2, 
are located between exons 8 and 9. By using the 
sequencing technique, new polymorphisms such as 
Cdx2 [17] in the promoter region have also been 
detected.  
Morrison et al. [12] found an association between 
bone mass and polymorphisms of the recognition sites 
of the restriction enzymes BsmI and ApaI in the 3'-end 
of the VDR gene, and in addition to the effect on 
mineral metabolism, several studies have investigated 
the relationship between  the VDR polymorphisms and 
diseases. The effect of VDR polymorphisms in renal 
failure has been explored, and Sezer et al. 
demonstrated that the BsmI polymorphism was 
related to the decreased recombinant human 
erythropoietin requirements needed to achieve higher 
hemoglobin levels among dialysis patients [18]. 
Associations between VDR polymorphisms and 
susceptibility and outcome have been indicated in 
prostate, lung, and colon cancers [19-21]. Zou et al. [20] 
suggested that VDR polymorphisms of Cdx2, FokI, and 
BsmI were associated with improved survival among 
squamous cell carcinoma patients with early-stage 
non-small-cell lung cancer. Furthermore, 
nephrolithiasis has been suggested as being related to 
the VDR FokI polymorphism [22].   
Some association studies involving the VDR, 
mostly the TaqI polymorphism and periodontal 
disease, have been conducted in different ethnic 
populations and settings [23,24], and a few studies 
have investigated the effect of VDR ApaI, BsmI, or FokI 
polymorphism on periodontitis. According these 
results, the A allele for ApaI and the f allele for FokI 
might be correlated with an increased risk of 
periodontitis [25,26]. However, none has confirmed 
the association between the VDR polymorphism and 
the risk of periodontal disease. Moreover, few studies 
have examined their effects on periodontitis, although 
the effects of combined VDR gene polymorphisms on 
BMD have been reported [27-29].   
Therefore, we examined the relationship between 
ApaI, BsmI, and FokI VDR polymorphisms and the 
risk of severe chronic periodontitis among Japanese 
adult men. A strong association between smoking and 
periodontal disease has been revealed in several 
previous studies [30-32]. In Japan, the smoking rate in 
males is the highest among industrialized countries, 
while the prevalence in females remains low [33]. We 
hypothesized that VDR polymorphisms would be 
associated with periodontal disease as an independent 
risk factor in spite of smoking. We focused on male 
subjects in this study. 
2.  MATERIALS AND METHODS   
Participants 
The subjects were employees in a Japanese 
c h e m i c a l  c o m p a n y .  T h i s  r e p o r t  i s  a  p a r t  o f  a  
cross-sectional study that was previously reported 
[34]. A total of 291 male subjects participated. Of these, 
97 subjects who gave informed consent for DNA 
analysis  were analyzed.  The participants were 
recruited and examined between September and 
October 2004. All volunteers signed written consent 
forms before participating.   
The study comprised 97 healthy Japanese males 
between 22 and 59 years of age (mean age: 45.6 years). 
A dental examination was conducted as a worksite 
health checkup. Venous blood samples were obtained 
before the examination, and weight and height were 
measured in all subjects. The body mass index (BMI) 
was computed by dividing the body weight in 
kilograms by the square of the height in meters. The 
mean (±SD) BMI was 23.3 ± 3.1 kg/m2, which is 
typical for healthy Japanese males. Information on 
smoking status was obtained using a self-reported 
questionnaire. Smoking status was assessed and 
subjects were classified as a “current smoker” or “not 
a current smoker.” A diagnosis of diabetes was made 
according to the Japan Diabetes Society criteria based 
on a fasting plasma glucose ≥126 mg/dl and HbA1c 
≥6.5%. 
Each participant was examined by either of two 
qualified dentists (K.H. and M.N.), who carried out 
the dental examinations throughout the study period. 
The diagnosis of periodontal disease and classification 
of its severity were established based on the clinical 
parameters of the Community Periodontal Index 
(CPI). The two dentists were assigned to subjects at 
random. Inter-examiner agreement of CPIs between 
the dentists was tested for seven volunteers before the 
dental examinations (kappa statistics = 0.77, p = 0.03). 
For CPI assessment, 3, 8, 14, 19, 24, and 30 were 
measured.  Each sextant was designed as either 
healthy (score 0); bleeding, but no dental calculus 
detected (score 1); calculus detected, but no pockets 
(score 2); a probing depth exceeding 4 mm (score 3); or 
a probing depth exceeding 6 mm (score 4), according 
to the highest score recorded at the index teeth. The 
highest score was recorded as the CPI score of the 
participant. Severe chronic periodontitis was defined 
as oral health status with a CPI of 4. Oral health status 
with CPIs between 0 and 3 was classified as having no 
severe chronic periodontitis. 
Approval for this study was obtained from the 
ethics committee of Keio University School of 
Medicine, Tokyo, Japan. 
Genotype determination 
DNA was extracted from whole blood using the 
phenol/chloroform method. The VDR polymorphism 
was genotyped using polymerase chain reaction (PCR) 
followed by melt curve analysis [35] with a 
LightTyper instrument (Roche Diagnostics, Penzberg, 
Germany). The primers and probes used for 
determining the ApaI, BsmI, and FokI single nucleotide 
polymorphisms (SNPs) in the VDR genes are listed in 
Table 1. According to the dbSNP for FokI SNPs, 
rs10735810 was used in this study. Int. J. Med. Sci. 2007, 4 
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Table 1. Primer and probe sequences for the three polymorphisms of the VDR gene 
 
VDR, vitamin D receptor; SNP, single-nucleotide polymorphism 
 
PCR was performed with 0.5 μM sense primer 
and 0.05 μM antisense primer in a reaction mixture 
containing 0.2 μM anchor probe, 0.2 μM sensor probe, 
10 ng dried DNA, 4.0  μM MgCl2, 0.5 μl 10× PCR 
buffer, 0.2 mM dNTP, and 0.5 U of Faststart DNA 
polymerase (Roche Diagnostics) in a total volume of 5 
μl. The cycling program consisted of an initial 
denaturation for 10 min at 94°C, 40 cycles of 15 s at 
94°C, 55°C for 15 s, and 72°C for 15 s, followed by a 
final extension for 2 min at 72°C. 
After PCR, the reaction products were denatured 
at 94°C for 60 s, annealed at 40°C for 60 s, and melted 
by heating from 40 to 80°C at a rate of 0.1°C/s. The 
melt curve data were collected and classified using the 
LightTyper genotyping software, and genotypes were 
determined. The absence or presence of the ApaI, 
BsmI, and FokI sites were designated as A, B, and F 
alleles and a, b, and f alleles, respectively. 
Statistical analysis 
The frequency of each of the three 
polymorphisms was tested against Hardy-Weinberg 
equilibrium using the χ2 test, which was also used to 
compare categorical variables. Differences in the 
anthropometric characteristics of the different VDR 
genotypes or haplotypes were compared using 
one-way analysis of variance. To calculate the odds 
ratios (ORs) and 95% confidence intervals (CIs), 
multiple logistic regression analysis was performed to 
quantify the association between severe chronic 
periodontitis and the VDR polymorphisms after 
adjusting for age, smoking status , number of teeth 
present, and prevalence of diabetes. 
A value of p < 0.05 was considered statistically 
significant for all analyses. All statistical analyses were 
performed using the Statistical Package for the Social 
Sciences Version 11 for Windows (SPSS Inc., Chicago, 
IL). 
3.  RESULTS 
Single nucleotide polymorphisms 
Table 2 shows the demographic features of the 
participants with the polymorphisms. The genotype 
frequency of each of the VDR ApaI,  BsmI, and FokI 
polymorphisms was consistent with Hardy-Weinberg 
equilibrium. The most frequent genotypes of the ApaI, 
BsmI, or FokI polymorphisms were AA, bb, and Ff, 
respectively. No one had the BB genotype of the BsmI 
polymorphism. No statistically significant differences 
were detected in age, BMI, the percentage of current 
smokers, the percentage of individuals suffering from 
diabetes, or clinical indicators for oral status and the 
three genotypes. The study subjects included 42 
current smokers (43.3%) and 2 diabetics (2.1%). 
The distribution of the CPI scores between 0 and 
4 were 13.4, 15.5, 14.4, 39.2, and 17.5%, respectively. 
Seventeen subjects were diagnosed with severe 
chronic periodontitis. While the   mean  (±SD) 
percentage of teeth with bleeding on probing and the 
mean (±SD) probing depth were 72.6 ± 29.3% and 
4.0  ± 0.8 mm, respectively, among subjects with 
severe chronic periodontitis, those figures were 37.2 
± 32.5% and 2.6 ± 0.6 mm among subjects without 
severe chronic periodontitis. No statistically 
significant differences were found in the mean (±SD) 
number of teeth present between subjects with and 
without severe chronic periodontitis (25.7 ± 2.1 and 
25.3  ± 4.4,  respectively). 
The FokI genotype and allele frequencies differed 
between the groups with and without severe chronic 
periodontitis (Table 3). Individuals with any genotype 
that contained the F allele were less likely to develop 
severe chronic periodontitis than those with the ff 
genotype (p  = 0.09). Furthermore, heterozygous Ff 
individuals had a lower risk of severe chronic Int. J. Med. Sci. 2007, 4 
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periodontitis than individuals who lacked the F allele 
(OR = 0.25; 95% CI = 0.06-0.95). The ApaI and BsmI 
polymorphisms did not show statistically significant 
differences in alleles or genotypes between the groups 
with or without severe chronic periodontitis. 
Combined polymorphisms 
Seven different haplotypes were identified after 
analyzing combinations of the genotype frequencies 
for the three VDR polymorphisms: Abf (39.2%), AbF 
(28.4%), abF (13.4%), abf (9.3%), aBf (6.7%), Abf (2.6%), 
and aBF (0.5%) (Table 4). These haplotypes combined 
to form 16 different genotypes, of which the most 
prevalent were AAbbFf (20.6%), AAbbff (13.4%), 
AAbbFF (12.4%), AabbFf (11.3%), and Aabbff (10.3%). 
The Abf haplotype was more common in individuals 
with severe chronic periodontitis than in those who 
did not have the disease. Moreover, the abF haplotype 
was less prevalent in individuals with severe chronic 
periodontitis than in those without severe chronic 
periodontitis. 
Table 5 shows the association between 
individuals who were carrying combined VDR 
polymorphisms and the prevalence of severe chronic 
periodontitis. For this purpose, the data obtained from 
participants possessing the most common haplotypes 
(Abf, AbF, and abF) were analyzed. The Abf 
homozygous individuals had a significantly higher 
prevalence of severe chronic periodontitis than the 
others, and adjustments for age, smoking status, 
number of teeth present, and prevalence of diabetes 
did not change this association (OR = 7.5; 95% CI = 
1.6-34.4; p = 0.01). After adjusting for age or for all 
covariates, the AbF homozygote had a higher 
prevalence of severe chronic periodontitis than the 
others, and the abF haplotype had a lower prevalence 
of severe chronic periodontitis. However, the 
differences among the groups were not statistically 
significant. 
Table 2. Characteristics of the study subjects according to the genotypes of the Apa I, Bsm I, and Fok I VDR polymorphisms 
 
VDR, vitamin D receptor; SD, standard deviation 
Table 3. Genotype and allele frequencies of Apa I, Bsm I, and Fok I VDR polymorphisms in subjects with and without severe chronic 
periodontitis 
 
† Adjusted for age 
‡ χ2 analysis (a carrier, B carrier, or F carrier versus each reference) 
VDR, vitamin D receptor; SNP, single-nucleotide polymorphism; OR, odds ratio; CI, confidence Interval Int. J. Med. Sci. 2007, 4 
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Table 4. Haplotype and genotype frequencies of the Apa I, BsmI, and Fok I VDR polymorphisms 
 
VDR, vitamin D receptor 
Table 5. Associations between the combined Apa I, Bsm I, and Fok I VDR polymorphisms and severe chronic periodontitis risk 
 
† Adjusted for age 
† † Adjusted for age, smoking status, number of teeth present, and prevalence of diabetes 
VDR, vitamin D receptor; OR, odds ratio; CI, confidence interval 
 
4.  DISCUSSION  
We examined the relationship between ApaI, 
BsmI, and FokI VDR polymorphisms and severe 
chronic periodontitis in Japanese males. We 
determined that haplotypes of these three 
polymorphisms were related to the prevalence of 
severe chronic periodontitis, while no statistically 
significant associations were found in the analysis of Int. J. Med. Sci. 2007, 4 
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individual polymorphisms.  A single case-control 
study has been conducted [25], which revealed that 
the VDR haplotype constructed from the TaqI, BsmI, 
and FokI VDR polymorphisms was correlated with an 
increased risk of periodontitis. To our knowledge, this 
is the first study to examine the association between 
periodontitis and haplotypes of the ApaI,  BsmI, and 
FokI VDR polymorphisms.   
Two previous studies on BsmI VDR 
polymorphisms conducted among Japanese [36] and 
Brazilian populations [37] found no statistically 
significant differences in the distribution of the BsmI 
VDR polymorphism between individuals with and 
without periodontal disease. Our data support those 
findings. Inagaki et al. [26] demonstrated an 
association between the ApaI VDR polymorphism and 
the progress of periodontal disease in adult men who 
participated in the Dental Longitudinal Study in the 
United States. Specifically, they reported that the loss 
of alveolar bone and clinical attachment occurred at 
the highest rate in the AA genotype of the ApaI VDR 
polymorphism compared to the Aa or aa genotypes. 
We found that the AA genotype was more likely to 
increase the risk of severe chronic periodontitis, 
although the differences among the genotypes were 
not statistically significant. 
Park et al. [25] indicated an association between 
the FokI VDR polymorphism and an increased risk of 
developing generalized aggressive periodontitis, 
whereas Tachi et al. [38] did not find such an 
association. Among the haplotypes of the three 
polymorphic sites, the Abf homozygote showed that a 
VDR allele positively affected the prevalence of severe 
chronic disease. The ff genotype of the FokI VDR 
polymorphism has been reported to convey stronger 
bone resorption and inflammation signals [25]. In our 
study, the F allele of the FokI VDR polymorphism was 
less likely to increase the risk of severe chronic 
periodontitis. This may support the proposal of Park 
et al. [25] that the FokI VDR polymorphism plays an 
important role in increasing the risk of developing 
periodontitis. 
Our findings suggest an important possibility 
when interpreting studies on the prevention of 
periodontitis for a parameter that generally has not 
been considered. In a series aimed at describing the 
clinical and microbial features over time in 
periodontal healthy adult subjects who received 
primary prevention, Bogren et al. [39] reported that the 
overall changes in clinical parameters were limited 
during a 3-year controlled trial with primary 
prevention for periodontitis. Although this study had 
limitations, such as a small sample size and 
cross-sectional study design, the data suggest that the 
combined VDR polymorphisms can predict 
periodontitis. Analyzing the combined VDR 
polymorphisms has the potential to guide 
individualized prevention and therapy; thus, further 
studies for confirmation are needed. 
Accumulated evidence indicates that diabetes is a 
major risk factor for periodontitis, and severe 
periodontitis often coexists with diabetes [40]. Taylor 
et al. [41] concluded that diabetics have a three- to 
fourfold increased risk of periodontitis. In addition, 
smoking has been established as the most important 
environmental risk factor for periodontitis [30], and 
cigarette smoking is a strong predictor of progressive 
periodontitis [31,32]. Cesar-Neto et al. [42] 
demonstrated that smoking modulated gene 
expression of cytokines in the periodontium, such as 
interleukin (IL)-6 and IL-10. The association between 
the Abf haplotype and periodontal disease that we 
observed was independent of current smoking status 
and the prevalence of diabetes as a statistical 
adjustment did not diminish the influence of the VDR 
haplotype on periodontal disease status. In fact, 
adjusting for those factors did not weaken this 
association. 
While we report a relationship between the VDR 
haplotype and periodontal disease, it remains unclear 
whether this association is valid among females, 
non-Asians, or people aged 60 years or more. Studies 
with larger sample size are also necessary for further 
discussion. When only the individual polymorphisms 
were analyzed and the haplotypes were not 
considered, these effects were not noticed [10]. 
Clearly, additional studies are needed to determine 
whether the combined VDR polymorphisms influence 
the risk of developing periodontitis under various 
settings. 
In conclusion, the VDR haplotype constructed 
from the ApaI, BsmI, and FokI VDR polymorphisms is 
related to the prevalence of severe chronic 
periodontitis in Japanese m e n .  A n a l y s i s  o f  V D R  
haplotype alleles may be useful for predicting the risk 
of developing periodontal disease. Further studies in 
gender-, ethnic-, or age-specific groups are needed. 
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